Loading company…
SCG Cell Therapy develops immunotherapies for infections and associated cancers.
SCG Cell Therapy develops T cell therapies, bispecific antibodies, and therapeutic vaccines targeting cancer-related infections and malignancies. Its work includes hepatitis B, helicobacter pylori, and human papillomavirus. Founded in 2017, the company is based in Singapore.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in